CASP8 and metabolic dysfunction-associated steatohepatitis: The possible reason for this result is that caspase-8 has a protective effect on preventing excess activation of necroptosis, and the key molecules of necroptosis may be the more potential targets for the treatment of NASH (Gautheron et al., 2014; Schwabe and Luedde, 2018).